ArticleTranslational oncology2021

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction.

Jatuporn Sujjitjoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.